59.97 USD
↘ 0.46 (0.76%)AT CLOSE (03:59 PM EDT)
Vaxcyte, Inc. Common Stock
PCVXNASDAQ • USD
59.65
↘ 0.32 (0.54%)
POST MARKET (AS OF 07:55 PM EDT)
Post Market
AS OF 07:55 PM EDT
59.65
↘ 0.32 (0.54%)
Market: CLOSED
Shares of Vaxcyte, Inc. Common Stock (PCVX) are trading at $59.95. Our models show a "Sell" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. PCVX is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Oct 26, 2026.
Open?$60.68
High?$61.50
Low?$59.19
Prev. Close?$60.43
Volume?1.5M
Avg. Volume?3.1M
VWAP?$59.88
Rel. Volume?0.47x
Bid / Ask
Bid?$58.80 × 100
Ask?$60.50 × 100
Spread?$1.70
Midpoint?$59.65
Valuation & Ratios
Market Cap?9.4B
Shares Out?148.8M
Float?130.6M
Float %?87.7%
P/E Ratio?N/A
P/B Ratio?3.42
EPS?-$6.76
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.
Employees
507
Market Cap
9.5B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2020-06-12
Address
825 INDUSTRIAL ROAD, STE. 300
SAN CARLOS, CA 94070
Phone: 650-837-0111
SAN CARLOS, CA 94070
Phone: 650-837-0111
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?23
Short Sent.?76
Piotroski F-Score?0/9Weak
Altman Z-Score?12.93Safe
Confidence?52%Low
Short InterestHigh
Short % of Float?11.20%High
Short Interest?14.6M
Days to Cover?2.9
Free Float130.6M
Avg Daily Volume5.1M
Settlement Date2026-10-15
Financial Health
Current Ratio?5.72Strong
Quick Ratio?5.72Strong
Cash Ratio?0.68Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?3.42FAIR▾
Peers100
S&P50
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-8.1CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-38.6%WEAK▾
S&P3
ROA?-33.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-921068000
Enterprise Value?$9.3B
Fundamentals ratios updated end of day